Novozymes North America Inc.
USPTO PatentsView assignee record - 33 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).
The verdict
According to USPTO PatentsView, Novozymes ranks #9,575 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 21 technology areas.
- #9,575
- of 49,997 US assignees by volume
- Top 41%
- by Innovation Score (38.3/100)
- 15.1
- avg claims per patent
- -75%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9575 · US Corporation #9,575 · 33 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 33 grants
- UPPER-Q #9,575/49,997
- PHOTO-FINISH National Institutes…
- CPC-FOCUS C12P · 21 areas
- INNOV-THIN 38.3/100
- CLAIMS-RICH 15.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -75% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: National Institutes for Quantum and Radiological Science and Technology (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Novozymes’s 38.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Novozymes
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Mitsubishi Jidosha… · near
Mitsubishi Jidosha… · near
38 score
- Brose Fahrzeugteile… · near
Brose Fahrzeugteile… · near
38 score
- Novozymes North… · this assignee
Novozymes North… · this assignee
38 score
- The Procter &… · near
The Procter &… · near
38 score
- FibroGen · near
FibroGen · near
38 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Novozymes's Innovation Score is 38.3/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Novozymes?
Each dot is one of Novozymes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novozymes’s own 15.1 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Novozymes's grants concentrate
Novozymes North America Inc. is a focused PatentsView assignee: 21 CPC subclasses with 81.8% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2017 (8 grants) versus a trough of 1 in 2023. By volume, Novozymes sits between National Institutes for Quantum and Radiological Science and Technology and Otoy Inc..
Novozymes's three-year grant acceleration
Novozymes North America Inc. shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Novozymes's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- National Institut…
National Institutes for Quantum and Radiological Science and Technology
33 patents
- Neotract
NeoTract, Inc.
33 patents
- Nomadix
Nomadix, Inc.
33 patents
- North Carolina Ag…
North Carolina Agricultural and Technical State University
33 patents
- Oculeve
Oculeve, Inc.
33 patents
- Osaka City Univer…
Osaka City University
33 patents
- Oslo Universitets…
Oslo Universitetssykehus
33 patents
- Otoy
Otoy Inc.
33 patents
- Novozymes North A… ◀
Novozymes North America Inc.
33 patents
What this shows Novozymes holds 33 patents at rank #9,574, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Novozymes
By rank, the assignees closest to #9,574 in granted patent volume.
- National Institutes for Quantum and Radiological Science and Technology #9,570 · 33 patents
- NeoTract, Inc. #9,571 · 33 patents
- Nomadix, Inc. #9,572 · 33 patents
- North Carolina Agricultural and Technical State University #9,573 · 33 patents
- Oculeve, Inc. #9,575 · 33 patents
- Osaka City University #9,576 · 33 patents
- Oslo Universitetssykehus #9,577 · 33 patents
- Otoy Inc. #9,578 · 33 patents
Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)
Other assignees with the most granted patents in Novozymes's primary technology class.
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Novozymes, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Novozymes ranks #65 of 1,268 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (38 here).
Novozymes's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 12.1% |
| 2016 | 6 | 18.2% |
| 2017 | 8 | 24.2% |
| 2018 | 3 | 9.1% |
| 2019 | 3 | 9.1% |
| 2020 | 3 | 9.1% |
| 2021 | 2 | 6.1% |
| 2023 | 1 | 3.0% |
| 2025partial year | 3 | 9.1% |
Which technologies does Novozymes North America Inc. patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Novozymes North America Inc.'s patent record in context - here's where to go next.
- Novozymes North America Inc.'s lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 81.8% of its portfolio - see every assignee active in that class. Explore C12P
- Ranked #9,575 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Novozymes North America Inc. against National Institutes for Quantum and Radiological Science and Technology, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 38.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.